Key result
Rapid carotid IMT progression linked to ~3-fold higher MACCE risk after myocardial infarction.
Why the study?
Patients after first myocardial infarction treated with PCI remain at high risk of ischemic event recurrence, necessitating objective markers of atherosclerosis control beyond pharmacotherapy and compliance.
Cohort (n=215)
Answers are grounded in this paper and cite their sources.
CIMT progression may refine post-MI risk stratification; leaves open whether serial monitoring improves outcomes or warrants practice change.
INTRODUCTION: Despite percutaneous coronary intervention (PCI), patients after their first myocardial infarction (MI) are at high risk of ischemic event recurrence. Therefore, there is a need for objective markers of adequate atherosclerosis control, independent of prescribed pharmacotherapy and patients' compliance. Such a potential indicator of major adverse cerebral and coronary event (MACCE) risk might be change in carotid intima-media thickness (CIMT), which indicates atherosclerosis growth. AIM: To evaluate the potential associations between CIMT changes and the incidence of MACCE and recurrent MI. MATERIAL AND METHODS: The CIMT assessments at baseline and during 2 follow-up visits were performed in 215 patients admitted with MI, in whom PCI was performed for an index lesion, followed by best medical treatment. The incidences of MACCE (cardiovascular death, recurrent MI, ischemic stroke) and new onset angina were recorded prospectively. An optimal cut-off value for annual CIMT change of > 0.003 mm/year (sensitivity: 84.5%, specificity: 49.3%) for MI plus CLP (AUC = 0.673) occurred an independent indicator of MACCE (HR = 3.00; 95% CI: 1.496-6.016), recurrent MI (HR = 4.59, 95% CI: 1.591-13.217), and MI plus CLP (HR = 3.50, 95% CI: 1.759-6.964). CONCLUSIONS: Annual CIMT change might be a potentially valuable marker of atherosclerosis response to post-MI treatment.
No takes yet. Share an insight, caveat, or question.
Gacoń et al. (2019) conducted a cohort in Recent myocardial infarction (n=215). Annual carotid intima-media thickness (CIMT) progression > 0.003 mm/year vs. Annual CIMT progression ≤ 0.003 mm/year was evaluated on Major adverse cerebral and coronary events (MACCE) (HR 3.00, 95% CI 1.496-6.016, p=< 0.001). An annual carotid intima-media thickness progression rate of > 0.003 mm/year was an independent indicator of increased risk for major adverse cerebral and coronary events in patients with a recent myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: